Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

BackgroundSARS-CoV-2 vaccination in rheumatoid arthritis (RA) patients treated with B cell-depleting drugs induced limited seroconversion but robust cellular response. We aimed to document specific T and B cell immunity in response to vaccine booster doses and breakthrough infection (BTI).MethodsWe...

Full description

Bibliographic Details
Published in:	Frontiers in Immunology
Main Authors:	Hassen Kared, Ingrid Jyssum, Amin Alirezaylavasani, Ingrid M. Egner, Trung The Tran, Lisa Tietze, Katrine Persgård Lund, Anne Therese Tveter, Sella A. Provan, Hilde Ørbo, Espen A. Haavardsholm, John Torgils Vaage, Kristin Jørgensen, Silje Watterdal Syversen, Fridtjof Lund-Johansen, Guro Løvik Goll, Ludvig A. Munthe
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-02-01
Subjects:	T cell B cell COVID-19 mRNA vaccination rheumatoid arthritis rituximab
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1296273/full

Similar Items

Hybrid and SARS-CoV-2-vaccine immunity in kidney transplant recipientsResearch in context
by: Hassen Kared, et al.
Published: (2023-11-01)

Robust spike-specific CD4+ and CD8+ T cell responses in SARS-CoV-2 vaccinated hematopoietic cell transplantation recipients: a prospective, cohort study
by: Lorenzo Federico, et al.
Published: (2023-07-01)

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination
by: Murat Gainullin, et al.
Published: (2024-01-01)

Vaccine responses and hybrid immunity in people living with HIV after SARS-CoV-2 breakthrough infections
by: Amin Alirezaylavasani, et al.
Published: (2024-10-01)

T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort studyResearch in context
by: Asia-Sophia Wolf, et al.
Published: (2024-10-01)

A strong case for third-party testing
by: Fridtjof Lund-Johansen
Published: (2023-11-01)

Humoral and cellular responses to a fifth bivalent SARS-CoV-2 vaccine dose in patients with immune-mediated inflammatory diseases on tumour necrosis factor inhibitors: a prospective cohort studyResearch in context
by: Hilde S. Ørbo, et al.
Published: (2025-01-01)

T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis
by: Asia-Sophia Wolf, et al.
Published: (2023-06-01)

Seroprevalence of SARS-CoV-2 and humoral immune responses to COVID-19 mRNA vaccines among people who use drugs - in the light of tailored mitigating strategies
by: Linda Elise Couëssurel Wüsthoff, et al.
Published: (2024-06-01)

Incidence and outcome of COVID-19 following vaccine and hybrid immunity in patients on immunosuppressive therapy: identification of protective post-immunisation anti-RBD antibody levels in a prospective cohort study
by: Tore K Kvien, et al.
Published: (2024-05-01)

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy
by: Jorgen Jahnsen, et al.
Published: (2022-11-01)

High-resolution antibody array analysis of proteins from primary human keratinocytes and leukocytes.
by: Daniel de la Rosa Carrillo, et al.
Published: (2018-01-01)

Corrigendum: Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
by: Lorenzo Federico, et al.
Published: (2024-02-01)

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence
by: Lorenzo Federico, et al.
Published: (2023-11-01)

A systematic safety pipeline for selection of T-cell receptors to enter clinical use
by: Zsofia Foldvari, et al.
Published: (2023-08-01)

Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
by: Trung The Tran, et al.
Published: (2023-01-01)

Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
by: Trung The Tran, et al.
Published: (2022-12-01)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
by: Arne Søraas, et al.
Published: (2022-09-01)

CD127 expression, exhaustion status and antigen specific proliferation predict sustained virologic response to IFN in HCV/HIV co-infected individuals.
by: Hassen Kared, et al.
Published: (2014-01-01)

Adaptive immune responses against common viruses are sustained and functional in end-of-life patients
by: Anna Olofsson, et al.
Published: (2025-03-01)

Effect of Bovaer inclusion in diets with a high proportion of grass-clover silage of different nutritional quality on gas emissions and production performance in dairy cows
by: Marianne Johansen, et al.
Published: (2025-05-01)

Characterization of the SARS-CoV-2 antibody landscape in Norway in the late summer of 2022: high seroprevalence in all age groups with patterns of primary Omicron infection in children and hybrid immunity in adults
by: Gro Tunheim, et al.
Published: (2024-08-01)

Expressions of a backlash: Challenging the story of success in Norwegian cinema of the 1980s and 1990s
by: Fosheim Lund Maria, et al.
Published: (2024-09-01)

Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial
by: Joseph Sexton, et al.
Published: (2024-11-01)

High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens
by: Katrine Fladeland Iversen, et al.
Published: (2022-08-01)

Omicron Variant Generates a Higher and More Sustained Viral Load in Nasopharynx and Saliva Than the Delta Variant of SARS-CoV-2
by: Beathe K. Granerud, et al.
Published: (2022-10-01)

An intranasal subunit vaccine induces protective systemic and mucosal antibody immunity against respiratory viruses in mouse models
by: Aina Karen Anthi, et al.
Published: (2025-05-01)

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
by: Saskia Meyer, et al.
Published: (2023-01-01)

Effect of dietary fat source and concentration on feed intake, enteric methane, and milk production in dairy cows
by: Giulio Giagnoni, et al.
Published: (2025-01-01)

A New Pathotype of Pea seedborne mosaic virus Explained by Properties of the P3-6k1- and Viral Genome-Linked Protein (VPg)-Coding Regions
by: Charlotte Kristiane Hjulsager, et al.
Published: (2002-02-01)

[Letter to the Editor] The need for improved education and training in research antibody usage and validation practices
by: Leonard P. Freedman, et al.
Published: (2016-07-01)

Comparing the impact of upfront radiosurgery versus expectation in vestibular schwannoma (the V-REX study): protocol for a randomised, observer-blinded, 4-year, parallel-group, single-centre, superiority study
by: Dhanushan Dhayalan, et al.
Published: (2021-03-01)

A history of flops and a new turn: The Turkish-German music interplay
by: Cornelia Lund, et al.
Published: (2022-05-01)

Quit smoking: methods and outcomes for Norwegian adults
by: Ingeborg Lund, et al.
Published: (2023-05-01)

Non-hematopoietic Control of Peripheral Tissue T Cell Responses: Implications for Solid Tumors
by: Ryan S. Lane, et al.
Published: (2018-11-01)

Polynomial Boundary Perturbation for Optimal Plastic Design of Heads of Plane Tension Members
by: W. Egner
Published: (1996-07-01)

Viden i læreruddannelsen – en typologi
by: Jens Hansen Lund, et al.
Published: (2020-06-01)

Sammenhæng i læreruddannelse
by: Jens H. Lund, et al.
Published: (2019-02-01)

Different dimensions of knowledge in teacher education - a general typification
by: Birgitte Lund Nielsen, et al.
Published: (2020-09-01)

Neurotrauma from fall accidents in Ethiopia
by: Tsegazeab Laeke, et al.
Published: (2024-01-01)